DEXCOM INC. DL-,001/ US2521311074 /
2024-06-06 9:52:59 PM | Chg. -3.30 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
105.78EUR | -3.03% | 1,217 Turnover: 129,731.14 |
105.58Bid Size: 142 | 106.12Ask Size: 141 | 42.11 bill.EUR | - | - |
GlobeNewswire
04-08
Precision Neuroscience Names Verily Co-Founder Brian Otis as Chief Technology Officer
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.